3-hydroxyflavone has been researched along with Bone Loss, Osteoclastic in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Chu, F; Jin, H; Kenny, J; Pan, H; Qiu, H; Tickner, J; Wang, C; Wang, Q; Wang, T; Wang, Z; Xu, H; Xu, J; Xu, K; Ye, Z | 1 |
Du, Y; Mao, Y; Shang, W; Yu, X; Zhang, S; Zhen, J; Zheng, F | 1 |
Cai, Q; Fan, KJ; Wang, QS; Wang, TY; Wu, J; Xu, BX | 1 |
Chen, A; Fang, H; Fang, J; Guo, F; Hou, X; Huang, S; Li, F; Li, X; Zhang, X | 1 |
Fukuma, Y; Fumimoto, R; Nishishita, K; Okamoto, K; Sakai, E; Sakamoto, H; Shimada-Sugawara, M; Tsukuba, T; Yamaguchi, Y | 1 |
Coxam, V; Guicheux, J; Léotoing, L; Miot-Noirault, E; Wauquier, F; Wittrant, Y | 1 |
Han, SY; Kang, SA; Kang, YH; Kim, JL; Kim, YH; Lee, EJ; Park, SH | 1 |
7 other study(ies) available for 3-hydroxyflavone and Bone Loss, Osteoclastic
Article | Year |
---|---|
Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Topics: Animals; Bone Resorption; Cells, Cultured; Drugs, Chinese Herbal; Female; Flavonols; Gene Expression; Humans; Integrin beta3; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Ovariectomy; Phytotherapy; Proto-Oncogene Proteins c-fos; RANK Ligand; RAW 264.7 Cells; Tartrate-Resistant Acid Phosphatase | 2019 |
Isorhamnetin 3-O-neohesperidoside promotes the resorption of crown-covered bone during tooth eruption by osteoclastogenesis.
Topics: Animals; Bone and Bones; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Flavonols; Gene Expression Regulation; Macrophages; Male; Mice; Mice, Inbred C57BL; Osteoclasts; Osteogenesis; Quercetin; RANK Ligand; Signal Transduction; Tooth Eruption | 2020 |
DMY protects the knee joints of rats with collagen-induced arthritis by inhibition of NF-κB signaling and osteoclastic bone resorption.
Topics: Animals; Arthritis, Experimental; Bone Resorption; Cartilage, Articular; Cell Line; Collagen; Flavonols; Knee Joint; Male; NF-kappa B; Osteoblasts; Osteoclasts; RANK Ligand; Rats; Rats, Wistar; Signal Transduction | 2020 |
(2R,3R)Dihydromyricetin inhibits osteoclastogenesis and bone loss through scavenging LPS-induced oxidative stress and NF-κB and MAPKs pathways activating.
Topics: Animals; Bone Resorption; Flavonols; Lipopolysaccharides; Male; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Osteogenesis; Oxidative Stress; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase | 2018 |
Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes.
Topics: Animals; Bone Resorption; Cell Differentiation; Dose-Response Relationship, Drug; Flavonoids; Flavonols; Gene Expression Regulation, Developmental; Heme Oxygenase-1; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NFATC Transcription Factors; Osteoclasts; Reactive Oxygen Species; Receptor Activator of Nuclear Factor-kappa B; Up-Regulation | 2013 |
The polyphenol fisetin protects bone by repressing NF-κB and MKP-1-dependent signaling pathways in osteoclasts.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Disease Models, Animal; Dual Specificity Phosphatase 1; Flavonoids; Flavonols; Gene Expression Regulation; Humans; MAP Kinase Kinase 4; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteoporosis; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-fos; RANK Ligand; Signal Transduction | 2013 |
Fisetin antagonizes cell fusion, cytoskeletal organization and bone resorption in RANKL-differentiated murine macrophages.
Topics: Animals; Bone Resorption; Cell Differentiation; Cell Fusion; Cytoskeleton; Flavonoids; Flavonols; Macrophages; Mice; RANK Ligand | 2014 |